Non-Applicability of Reg. 57(5) of SEBI (LODR) Regulations, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transgene Biotek Ltd has informed BSE that SEBI Regulation 57(5) does not apply to the company for the quarter and year ended 31 March 2025. The regulation deals with reporting obligations related to non-convertible securities (such as NCDs), and the company states it has not issued any such instruments. As a result, both the certificate confirming payment of interest/dividend/principal and the disclosure of unpaid obligations are marked as 'Not Applicable.' The letter is signed by Dr. K. Koteswara Rao, Chairman & Managing Director.
This is a routine compliance filing with no material impact on shareholders or the stock price. It simply confirms the company does not have non-convertible debt securities, so no new financial obligations or events are being disclosed.